FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016982251> ?p ?o ?g. }

• W2016982251 endingPage "1271" @default.
• W2016982251 startingPage "1263" @default.
• W2016982251 abstract "MIG (monokine induced by interferon-gamma) is a CXC chemokine ligand (CXCL9) that can potently inhibit angiogenesis, and displays thymus-dependent antitumor effects. The effectiveness of a treatment combining gene therapy with plasmid-borne MIG (pORF-MIG) and low-dose cisplatin chemotherapy was determined using colon carcinoma (CT26) and Lewis lung carcinoma (LL/2c) murine models. The program was carried out via intramuscular delivery of pORF-MIG at 100 mug/mouse twice a week for 4 weeks, and/or intraperitoneal delivery of cisplatin at 0.6 mg/kg/mouse every 3 days for 48 days. Tumor volume and survival time were evaluated after treatment. CD31 immunohistochemical staining in tumor tissues and alginate capsule models in vivo was used to evaluate angiogenesis. Induction of apoptosis and cytotoxic T-lymphocyte (CTL) activity were also assessed. The combination of pORF-MIG and low-dose cisplatin produced significant antitumor activity, with complete tumor regression in 4/10 of CT26 colon carcinomas and 3/10 of LL/2c lung carcinomas, low vascularity, in alginate capsules, apparently degraded tumor microvessel density, and increased induction of apoptotic and CTL activities compared with either treatment alone. This study suggests that the combination of pORF-MIG plus cisplatin augments the inhibition of angiogenesis and the induction of apoptosis or CTL activity, all of which enhance antitumor activity. These findings may prove useful in further explorations of the application of combinatorial approaches to the treatment of solid tumors." @default.
• W2016982251 created "2016-06-24" @default.
• W2016982251 creator A5001504110 @default.
• W2016982251 creator A5015335960 @default.
• W2016982251 creator A5027037131 @default.
• W2016982251 creator A5027452521 @default.
• W2016982251 creator A5032988856 @default.
• W2016982251 creator A5042459576 @default.
• W2016982251 creator A5050327059 @default.
• W2016982251 creator A5052883326 @default.
• W2016982251 creator A5058006003 @default.
• W2016982251 creator A5066141529 @default.
• W2016982251 creator A5070619473 @default.
• W2016982251 creator A5076295006 @default.
• W2016982251 creator A5084425570 @default.
• W2016982251 creator A5084629720 @default.
• W2016982251 creator A5086592087 @default.
• W2016982251 creator A5090596512 @default.
• W2016982251 date "2006-05-04" @default.
• W2016982251 modified "2023-10-15" @default.
• W2016982251 title "Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma" @default.
• W2016982251 cites W1525077036 @default.
• W2016982251 cites W1545819550 @default.
• W2016982251 cites W1579297325 @default.
• W2016982251 cites W1621599087 @default.
• W2016982251 cites W1649281945 @default.
• W2016982251 cites W1970847065 @default.
• W2016982251 cites W1997356690 @default.
• W2016982251 cites W1998605540 @default.
• W2016982251 cites W2013192123 @default.
• W2016982251 cites W2016865916 @default.
• W2016982251 cites W2022662750 @default.
• W2016982251 cites W2029883816 @default.
• W2016982251 cites W2030516961 @default.
• W2016982251 cites W2048781289 @default.
• W2016982251 cites W2052877553 @default.
• W2016982251 cites W2062036842 @default.
• W2016982251 cites W206539972 @default.
• W2016982251 cites W2075015509 @default.
• W2016982251 cites W2078318361 @default.
• W2016982251 cites W2085840728 @default.
• W2016982251 cites W2086073957 @default.
• W2016982251 cites W2104676417 @default.
• W2016982251 cites W2107236288 @default.
• W2016982251 cites W2112430693 @default.
• W2016982251 cites W2115183912 @default.
• W2016982251 cites W2118526748 @default.
• W2016982251 cites W2127543743 @default.
• W2016982251 cites W2129154410 @default.
• W2016982251 cites W2129980000 @default.
• W2016982251 cites W2143372911 @default.
• W2016982251 cites W2150782063 @default.
• W2016982251 cites W2153869022 @default.
• W2016982251 cites W2155056678 @default.
• W2016982251 cites W2162149445 @default.
• W2016982251 cites W2234354671 @default.
• W2016982251 cites W2324677651 @default.
• W2016982251 cites W23627017 @default.
• W2016982251 cites W4211264883 @default.
• W2016982251 cites W4313376938 @default.
• W2016982251 doi "https://doi.org/10.1038/sj.gt.3302756" @default.
• W2016982251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16672984" @default.
• W2016982251 hasPublicationYear "2006" @default.
• W2016982251 type Work @default.
• W2016982251 sameAs 2016982251 @default.
• W2016982251 citedByCount "56" @default.
• W2016982251 countsByYear W20169822512012 @default.
• W2016982251 countsByYear W20169822512014 @default.
• W2016982251 countsByYear W20169822512015 @default.
• W2016982251 countsByYear W20169822512016 @default.
• W2016982251 countsByYear W20169822512017 @default.
• W2016982251 countsByYear W20169822512018 @default.
• W2016982251 countsByYear W20169822512019 @default.
• W2016982251 countsByYear W20169822512020 @default.
• W2016982251 countsByYear W20169822512021 @default.
• W2016982251 countsByYear W20169822512022 @default.
• W2016982251 countsByYear W20169822512023 @default.
• W2016982251 crossrefType "journal-article" @default.
• W2016982251 hasAuthorship W2016982251A5001504110 @default.
• W2016982251 hasAuthorship W2016982251A5015335960 @default.
• W2016982251 hasAuthorship W2016982251A5027037131 @default.
• W2016982251 hasAuthorship W2016982251A5027452521 @default.
• W2016982251 hasAuthorship W2016982251A5032988856 @default.
• W2016982251 hasAuthorship W2016982251A5042459576 @default.
• W2016982251 hasAuthorship W2016982251A5050327059 @default.
• W2016982251 hasAuthorship W2016982251A5052883326 @default.
• W2016982251 hasAuthorship W2016982251A5058006003 @default.
• W2016982251 hasAuthorship W2016982251A5066141529 @default.
• W2016982251 hasAuthorship W2016982251A5070619473 @default.
• W2016982251 hasAuthorship W2016982251A5076295006 @default.
• W2016982251 hasAuthorship W2016982251A5084425570 @default.
• W2016982251 hasAuthorship W2016982251A5084629720 @default.
• W2016982251 hasAuthorship W2016982251A5086592087 @default.
• W2016982251 hasAuthorship W2016982251A5090596512 @default.
• W2016982251 hasBestOaLocation W20169822511 @default.
• W2016982251 hasConcept C104317684 @default.
• W2016982251 hasConcept C111599444 @default.
• W2016982251 hasConcept C121608353 @default.

• next